Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anxiety disorders have been linked to an increased risk of incident coronary heart disease in which inflammation plays a key pathogenic role. To date, no studies have looked at the association between proinflammatory markers and agoraphobia. METHODS: In a random Swiss population sample of 2890 persons (35-67 years, 53% women), we diagnosed a total of 124 individuals (4.3%) with agoraphobia using a validated semi-structured psychiatric interview. We also assessed socioeconomic status, traditional cardiovascular risk factors (i.e., body mass index, hypertension, blood glucose levels, total cholesterol/high-density lipoprotein-cholesterol ratio), and health behaviors (i.e., smoking, alcohol consumption, and physical activity), and other major psychiatric diseases (other anxiety disorders, major depressive disorder, drug dependence) which were treated as covariates in linear regression models. Circulating levels of inflammatory markers, statistically controlled for the baseline demographic and health-related measures, were determined at a mean follow-up of 5.5 ± 0.4 years (range 4.7 - 8.5). RESULTS: Individuals with agoraphobia had significantly higher follow-up levels of C-reactive protein (p = 0.007) and tumor-necrosis-factor-α (p = 0.042) as well as lower levels of the cardioprotective marker adiponectin (p = 0.032) than their non-agoraphobic counterparts. Follow-up levels of interleukin (IL)-1β and IL-6 did not significantly differ between the two groups. CONCLUSIONS: Our results suggest an increase in chronic low-grade inflammation in agoraphobia over time. Such a mechanism might link agoraphobia with an increased risk of atherosclerosis and coronary heart disease, and needs to be tested in longitudinal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“| Tumor necrosis factor-α | Increased in GAD and PD | Hoge et al (2009),Vieira et al (2010), and Wagner et al (2015) |”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Wagner et al (2015)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, in a sample of patients with agoraphobia, no difference in mean level of CRP compared with controls was found, although agoraphobic patients did show a significant increase in CRP levels over time, whereas controls did not (Wagner et al, 2015).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Wagner et al, 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| C-reactive protein | Increased in GAD | Bankier et al (2008),Copeland et al (2012), and Wagner et al (2015) |”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Wagner et al (2015)
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| C-reactive protein | Increased in GAD | Bankier et al (2008),Copeland et al (2012), and Wagner et al (2015) |”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Wagner et al (2015)
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“| Tumor necrosis factor-α | Increased in GAD and PD | Hoge et al (2009),Vieira et al (2010), and Wagner et al (2015) |”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Wagner et al (2015)
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
(2000) · PubMed · Cited by 13,173
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Four Factor Index of Social Status
Paschou, R. (1975) · Cited by 6,989
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 1×
“One such adaptation might consist of a decrease of cortisol levels and a consecutively insufficient glucocorticoid signaling, causing excessive levels of cell-mediated and proinflammatory cytokines, as well as excessive stimulation of the hypothalamic-pituitary-adrenal (HPA) axis [8–10].”
BackgroundThe detection of psychiatric illness by questionnaire
Goldberg, D. P. (1972) · Oxford University Press eBooks · Cited by 5,075
Diagnostic Interview for Genetic Studies: Rationale, Unique Features, and Training
Nurnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,053
Twenty years of research on cytokine-induced sickness behavior
Dantzer, R., & Kelley, K. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.006 · Cited by 1,420
Stress and cardiovascular disease
Steptoe, A., & Kivimäki, M. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.45 · Cited by 1,321
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
Sternberg, E. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1810 · Cited by 1,064
Multiplexed particle-based flow cytometric assays
Vignali, D. A. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00238-6 · Cited by 913
Anxiety and Risk of Incident Coronary Heart Disease
Roest, A. M., Martens, E. J., de Jonge, P., & Denollet, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.034 · Cited by 865
Firmann, M., Mayor, V., Vidal, P. M., Bochud, M., Pécoud, A., Hayoz, D., Paccaud, F., Preisig, M., Song, K. S., Yuan, X., et al. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-6 · Cited by 721
Self-citationKaptoge, S., Seshasai, S. R. K., Gao, P., Freitag, D. F., Butterworth, A. S., Borglykke, A., Di Angelantonio, E., Gudnason, V., Rumley, A., Lowe, G. D. O., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht367 · Cited by 666
The Assessment of Alcohol Consumption by a Simple Self-administered Questionnaire
Glovannucci, E., Colditz, G., Stampfer, M. J., Rimm, E. B., Litin, L., Sampson, L., & Willett, W. C. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115960 · Cited by 637 · cited 1×
“Questionnaire-based data on alcohol consumption have been shown to correlate well with daily alcohol intake over the previous 4 years [39].”
MethodInflammation and Thrombosis: The Clot Thickens
Libby, P., & Simon, D. I. (2001) · Circulation · doi:10.1161/01.cir.103.13.1718 · Cited by 605
Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA☆
ELSHAL, M., & MCCOY, J. (2006) · Methods · doi:10.1016/j.ymeth.2005.11.010 · Cited by 568
Cytokine Dysregulation, Inflammation and Well-Being
Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000087104 · Cited by 502
Anxiety disorders and inflammation in a large adult cohort
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.27 · Cited by 458 · cited 1×
“However, that study did not investigate an association between inflammation and agoraphobia separately and applied a cross-sectional design [20].”
Backgroundvon Känel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., & Schnyder, U. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.06.009 · Cited by 408
The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands
de Vries, G., & Olff, M. (2009) · Journal of Traumatic Stress · doi:10.1002/jts.20429 · Cited by 390
Assessment of Plasma C-Reactive Protein as a Biomarker of Posttraumatic Stress Disorder Risk
Eraly, S. A., Nievergelt, C. M., Maihofer, A. X., Barkauskas, D. A., Biswas, N., Agorastos, A., O’Connor, D. T., & Baker, D. G. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4374 · Cited by 386 · cited 8×
“In comparison to PTSD, knowledge about the association between inflammation and agoraphobia is scarce—despite the fact that agoraphobia is one of the most prevalent, persistent and disabling of the mental disorders [15], with a well-known poor prognosis and frequent incomplete remission [15, 16].”
BackgroundInfluentialBekker, M. H. J., & van Mens-Verhulst, J. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80057-x · Cited by 362
Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder
Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., & Simon, N. M. (2009) · Depression and Anxiety · doi:10.1002/da.20564 · Cited by 343
Pace, T. W. W., & Heim, C. M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.003 · Cited by 321 · cited 2×
“Our findings of an association between agoraphobia and low-grade inflammation concur with studies on individuals with PTSD [2–5, 7, 11].”
BackgroundResultduPont, N. C., Wang, K., Wadhwa, P. D., Culhane, J. F., & Nelson, E. L. (2005) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2005.03.005 · Cited by 318
Preisig, M., Fenton, B. T., Matthey, M.-L., Berney, A., & Ferrero, F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050084 · Cited by 307
Self-citationWhat is moderate drinking? Defining "drinks" and drinking levels.
Dufour, M. C. (1999) · Alcohol research · Cited by 303
PTSD is associated with an excess of inflammatory immune activities
Gill, J. M., Saligan, L., Woods, S., & Page, G. (2009) · Perspectives in Psychiatric Care · doi:10.1111/j.1744-6163.2009.00229.x · Cited by 271
Preisig, M., Waeber, G., Vollenweider, P., Bovet, P., Rothen, S., Vandeleur, C., Guex, P., Middleton, L., Waterworth, D., Mooser, V., et al. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-9 · Cited by 240
Self-citationWhat is moderate drinking? Defining "drinks" and drinking levels.
Dufour, M. (1999) · PubMed · Cited by 235
Adipocytokines in relation to cardiovascular disease
Van de Voorde, J., Pauwels, B., Boydens, C., & Decaluwé, K. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.004 · Cited by 215
Pervanidou, P., Kolaitis, G., Charitaki, S., Margeli, A., Ferentinos, S., Bakoula, C., Lazaropoulou, C., Papassotiriou, I., Tsiantis, J., & Chrousos, G. P. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.07.001 · Cited by 183
EFFECTS OF SAMPLE HANDLING ON THE STABILITY OF INTERLEUKIN 6, TUMOUR NECROSIS FACTOR-α AND LEPTIN
Flower, L., Ahuja, R. H., Humphries, S. E., & Mohamed-Ali, V. (2000) · Cytokine · doi:10.1006/cyto.2000.0764 · Cited by 178
Buist‐Bouwman, M. A., De Graaf, R., Vollebergh, W. A. M., Alonso, J., Bruffaerts, R., Ormel, J., & the ESEMeD/MHEDEA 2000 investigators (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00684.x · Cited by 168
Ulijaszek, S. J. (2003) · Journal of Biosocial Science · doi:10.1017/s0021932003245508 · Cited by 155
Agoraphobia: a review of the diagnostic classificatory position and criteria
Wittchen, H.-U., Gloster, A. T., Beesdo-Baum, K., Fava, G. A., & Craske, M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20646 · Cited by 150 · cited 2×
“3%, which is situated within the lower bound of prevalences reported in other studies, ranging from 1% to 22% [18].”
Backgroundvan Zuiden, M., Kavelaars, A., Geuze, E., Olff, M., & Heijnen, C. J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.015 · Cited by 139
Psychosocial stress and cardiovascular risk – current opinion
Von Känel, R. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13502 · Cited by 137
Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn326 · Cited by 102
O’Donovan, A., Neylan, T. C., Metzler, T., & Cohen, B. E. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.02.003 · Cited by 90
Berney, A., Preisig, M., Matthey, M., Ferrero, F., & Fenton, B. T. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00156-9 · Cited by 90
Self-citationHamer, M., Gibson, E. L., Vuononvirta, R., Williams, E. D., & Steptoe, A. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.01.001 · Cited by 88
Rougemont-Buecking, A., Rothen, S., Jeanprêtre, N., Lustenberger, Y., Vandeleur, C. L., Ferrero, F., & Preisig, M. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.022 · Cited by 47 · cited 1×
“The inter-rater reliability for specific anxiety disorders was very good, whereas the 6-week test-retest reliability estimates were in the fair or good ranges [30].”
BackgroundSelf-citationImmunological response to stress in agoraphobia and panic attacks
Surman, O. S., Williams, J. M., Sheehan, D. V., Strom, T. B., Jones, K. J., & Coleman, J. H. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90242-8 · Cited by 37
Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V
Charney, D. S., Sirovatka, P. J., & Regier, D. A. (2008) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427750 · Cited by 32
Bromocriptine and Puerperal Seizures
Rothman, K. J., Funch, D. P., & Dreyer, N. A. (1990) · Epidemiology · doi:10.1097/00001648-199005000-00009 · Cited by 25
Skeppholm, M., Wallén, N. H., Blombäck, M., & Kallner, A. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.219 · Cited by 19
Problematic verbal patterns of a group psychotherapist
Kline, P. M. (1967) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.1967.tb01203.x · Cited by 2
Cited by
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
Renna, M. E., O'Toole, M. S., Spaeth, P. E., Lekander, M., & Mennin, D. S. (2018) · Depression and Anxiety · doi:10.1002/da.22790 · Cited by 220
Hou, R., Garner, M., Holmes, C., Osmond, C., Teeling, J., Lau, L., & Baldwin, D. S. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.021 · Cited by 191
Won, E., & Kim, Y.-K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186546 · Cited by 178
Old Friends, immunoregulation, and stress resilience
Langgartner, D., Lowry, C. A., & Reber, S. O. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2228-7 · Cited by 80
Metadata
- Authors
- Wagner, E.-Y. N., Wagner, J. T., Glaus, J., Vandeleur, C. L., Castelao, E., Strippoli, M.-P. F., Vollenweider, P., Preisig, M., & von Känel, R.
- Affiliations
- University Hospital of Bern (CH)
- Swissmedic (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Wagner, En-Young N.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-13
- Volume
- 10
- Issue
- 4
- Pages
- e0123757
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4395271
- OpenAlex
- W2033541273
- Cited by
- 40
- References
- 52
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 2
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open Access CRIS of the University of Bern
- Funders
- National Science Foundation (33CS30-139468, 33CS30-148401, 33CSCO-122661)
- GlaxoSmithKline (33CSCO-122661, 33CS30-139468 and 33CS30-148401, 3200B0–105993, 33CSCO-122661, 3200B0-118308, 33CS30-148401, 33CS30-139468)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (148401, 122661, 33CSCO, 118308, 105993, 3200B0, 33CS30, 139468)
- Chinese Society of Clinical Oncology
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- agoraphobia, low-grade inflammation, pro-inflammatory markers, C-reactive protein, TNF-α, adiponectin, interleukin-6, IL-1β, coronary heart disease risk, atherosclerosis, anxiety disorders, cardiovascular risk factors
- MeSH terms
- Adult, Aged, Agoraphobia, Chronic Disease, Female, Follow-Up Studies, Humans, Inflammation, Male, Middle Aged, Models, Biological, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.